Evidence map›Paper›PMID 32382933›Full record

ReviewApplied microbiology and biotechnology2020

Fungal RNA editing: who, when, and why?

Ines Teichert

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Characterization ofFrontiers in plant science · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Lactobacillus for ribosome peptide editing cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Review
  9. Review
  10. Journal of fungi (Basel, Switzerland) · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ines TeichertGeneral and Molecular Botany, Ruhr-University Bochum, 44780, Bochum, Germany. ines.teichert@rub.de.ORCID https://orcid.org/0000-0002-2993-6756
University Hospitals of the Ruhr-University of Bochum · DE

Funding

Deutsche Forschungsgemeinschaft TE977/2-1
6 · The paper itself

Abstract

RNA editing occurs in all kingdoms of life and in various RNA species. The editing of nuclear protein-coding transcripts has long been known in metazoans, but was only recently detected in fungi. In contrast to many metazoan species, fungal editing sites occur mostly in coding regions, and therefore, fungal editing can change protein sequences and lead to modified or new functions of proteins. Indeed, mRNA editing is thought to be generally adaptive on fungi. Although RNA editing has been detected in both, Ascomycota and Basidiomycota, there seem to be considerable differences between these two classes of fungi concerning the types, the timing, and the purpose of editing. This review summarizes the characteristics of RNA editing in fungi and compares them to metazoan species and bacteria. In particular, it will review cellular processes affected by editing and speculate on the purpose of editing for fungal biology with a focus on the filamentous ascomycetes. KEY POINTS: • Fungi show various types of mRNA editing in nuclear transcripts. • Fungal editing leads to proteome diversification. • Filamentous ascomycetes may require editing for sexual sporulation. • Wood-degrading basidiomycetes may use editing for adaptation to different substrates.

Indexed as

RNA EditingAdaptation, PhysiologicalAscomycotaBiological EvolutionFungal ProteinsFungiGene Expression Regulation, FungalRNA, FungalRNA, MessengerSpores, FungalFungal ProteinsRNA, FungalRNA, MessengerAdaptationADARADATDevelopmentFungiRNA editing

Identifiers

PMID32382933
PMCPMC7306014
OpenAlexW3023797984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.